Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof

Details for Australian Patent Application No. 2004261724 (hide)

Owner Istituto Di Ricerche Di Biologia Molecolare P Angeletti SPA

Inventors Gallo, Pasquale; Nuzzo, Maurizio; Monaci, Paolo

Agent Spruson & Ferguson

Pub. Number AU-B-2004261724

PCT Pub. Number WO2005/012527

Priority 60/489,237 21.07.03 US

Filing date 20 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 17 June 2010

International Classifications

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012527 Priority application(s): WO2005/012527

17 June 2010 Application Accepted

  Published as AU-B-2004261724

14 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261727-Method for checking or calibrating the angle-dependent alignment of a highprecision test-piece

2004261718-Borehole treating substance containing ether carboxylic acids